Hypertension Management Guidelines

Diagnosis and Treatment

The American Heart Association recommends confirming hypertension using validated automated upper arm cuff devices with appropriate cuff size, measuring BP in both arms and using the higher reading 1, 2, 3
Office BP ≥140/90 mmHg defines hypertension, but must be confirmed with home BP monitoring (≥135/85 mmHg) or 24-hour ambulatory monitoring (≥130/80 mmHg) 1, 2, 3
Assess for target organ damage, cardiovascular risk factors, diabetes, chronic kidney disease, and secondary causes of hypertension 3

The American College of Cardiology recommends lifestyle interventions for all patients, including dietary changes, physical activity, weight management, alcohol moderation, and smoking cessation 1, 2, 3
Implement DASH or Mediterranean diet with reduced sodium intake, increased potassium, and low-fat dairy products 3
At least 150 minutes of moderate-intensity aerobic exercise weekly plus resistance training 2-3 times per week 3

For non-Black patients, the preferred initial approach is two-drug combination therapy as single-pill combination 3
First-line treatment is low-dose ACE inhibitor or ARB + dihydropyridine calcium channel blocker 1, 2, 3
For Black patients, the preferred initial approach is low-dose ARB + dihydropyridine calcium channel blocker OR calcium channel blocker + thiazide-like diuretic 1, 2, 3

The American Heart Association recommends a blood pressure target of <130/80 mmHg for most adults 3
For adults with diabetes, CKD, or established CVD, the target is also <130/80 mmHg 4, 3
Initial goal is to reduce BP by at least 20/10 mmHg 1, 2

Achieve target BP within 3 months of initiating treatment 1, 2, 3
Schedule follow-up within 2-4 weeks initially to assess response and tolerability 5
Check serum creatinine and potassium 7-14 days after starting or adjusting ACE inhibitors, ARBs, or mineralocorticoid receptor antagonists 3

Never combine two RAS blockers (ACE inhibitor + ARB) as this is potentially harmful 3
Avoid clinical inertia: immediate combination therapy is more effective than sequential monotherapy titration 1, 2, 3
Do not discontinue lifestyle modifications once drug therapy starts—they are complementary and may reduce medication requirements 4, 3

The American Heart Association recommends comprehensive lifestyle changes, including a DASH diet pattern with 8-10 servings of fruits and vegetables daily, 2-3 servings of low-fat dairy products, reduced saturated and trans fats, to lower BP by 10-20 mmHg 6
Sodium restriction to <1500 mg/day or minimally reduce by at least 1000 mg/day is recommended to manage hypertension 6
Potassium supplementation of 3500-5000 mg/day through dietary sources is suggested to help lower blood pressure 6
Aerobic exercise of 90-150 minutes per week of moderate-intensity activity is recommended for patients with hypertension 6
Resistance training, including dynamic resistance exercise 90-150 minutes/week or isometric resistance 3 sessions/week, is recommended to manage hypertension 6
Weight loss, targeting ideal body weight or minimum 1 kg reduction if overweight/obese, is recommended to manage hypertension 6
Alcohol moderation, ≤2 drinks per day in men, ≤1 per day in women, is recommended to manage hypertension 6

For Stage 2 hypertension (≥160/100 mmHg), the American College of Cardiology recommends immediately initiating two antihypertensive medications simultaneously to achieve more rapid blood pressure control 7
The American Diabetes Association recommends ACE inhibitor or ARB as first-line treatment for patients with diabetes and albuminuria (urine albumin-to-creatinine ratio ≥30 mg/g) 7
For patients with chronic kidney disease, ACE inhibitor or ARB at maximum tolerated dose is recommended as first-line treatment, especially with albuminuria 7

The American Heart Association recommends scheduling follow-up within 2-4 weeks initially to assess response and tolerability, then monthly for drug titration until BP is controlled 6
Once controlled, recheck every 3-6 months, and encourage home BP monitoring throughout treatment 6
Before adding medications for apparent resistant hypertension, verify medication adherence, identify interfering medications, and screen for secondary causes, including primary aldosteronism, obstructive sleep apnea, and renal artery stenosis 6

The American College of Cardiology warns against combining two RAS blockers (ACE inhibitor + ARB) as this increases adverse events, including hyperkalemia and acute kidney injury, without additional cardiovascular benefit 7

For patients with Stage 1 Hypertension (130-139/80-89 mmHg), the American College of Physicians recommends starting pharmacologic therapy if the patient has established cardiovascular disease or a 10-year ASCVD risk ≥10% 8
For patients with Stage 2 Hypertension (≥140/90 mmHg), the American College of Physicians recommends initiating pharmacologic therapy immediately, typically with two antihypertensive agents from different classes 8
For patients with Severely Elevated BP (≥160/100 mmHg), the American College of Physicians recommends promptly starting dual therapy with careful monitoring and rapid dose titration to achieve control 8

For Black patients, the American Heart Association recommends a preferred initial regimen of dihydropyridine calcium channel blocker + thiazide-like diuretic, as calcium channel blockers and thiazides are more effective than ACE inhibitors/ARBs as monotherapy 9
For patients with Heart Failure, the American Heart Association recommends a compelling indication regimen of ACE inhibitor or ARB + beta-blocker + diuretic (usually loop diuretic if volume overloaded) 9
For patients with Chronic Kidney Disease, the American College of Physicians recommends a target BP of <130/80 mmHg, and monitoring serum creatinine and potassium 2-4 weeks after initiating or adjusting ACE inhibitor/ARB therapy 8

For most adults <65 years, the American College of Physicians recommends a blood pressure target of <130/80 mmHg 8
For adults ≥65 years, the American College of Physicians recommends a systolic blood pressure target of <130 mmHg, although this is not directly cited, the minimum acceptable target for all patients is <140/90 mmHg 8
For patients with Diabetes or Chronic Kidney Disease, the American College of Physicians recommends a blood pressure target of <130/80 mmHg 8
The minimum acceptable target for all patients is <140/90 mmHg, as recommended by the American Heart Association and the American College of Physicians [8] [10] 9